. .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . . .cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months. . . . explore xinhuanet http://lm360.us/Caperton-mother-of-Thielemier-from-Bhartiya?Sossongmo=86 .